Answers are grounded in this paper and cite their sources.
Single nucleotide polymorphisms (SNPs) located in non-coding regions of the human genome that have been found to be significantly associated with disease or sickness may affect gene regulation by altering binding sites for transcription factors (TF). There have been several reports to identify such punitive changes in transcriptional factor binding sites (TFBS) created by SNP alleles. A few of these reports have been reviewed for the Activating Transcription Factor 3 (ATF3), v-Akt Murine Thymoma Viral Oncogene Homolog 3 (AKT3), Adrenergic Beta Receptor Kinase 1 (G Protein-Coupled Receptor Kinase 2) (ADRBK1), Type 2 Deiodeinase (DIO2), Endothetal Per-Arnt-Sim(PAS)domain protein 1 (EPAS1), Lysosomal Acid Lipase A (LIPA), Peroxisome Proliferator-activated Receptors (PPAR//), Signal Transducer and Activator of Transcription 4 (STAT4), Thromboxane A2 Receptor (TBXA2R) and Vascular Endothelial Growth Factor (VEGF)-A genes. In each report the SNP alleles created punitive alterations in TFBS that could explain associated disease(s) or changes in a human condition.
No takes yet. Share an insight, caveat, or question.
Norman E. Buroker (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: